Three-quarters of CAC2 member organizations fund essential
research projects related to childhood and AYA cancer.
The Research and Treatment Interest Group strives to establish CAC2 as a credible resource for moving the field of pediatric cancer forward through thoughtful, progressive studies and projects.
The coverage is deep and broad: across the spectrum of development, from basic research through to clinical trials; across a wide range of topics, including data sharing, crucial medicines, psycho-social standards, and survivorship; and across the country and around the world.
Research funded by our members is crucial to discovering more effective treatments that minimize side effects and increase quality of life during and after treatment.
Most importantly, that research investment represents a shared aim to find cures for all types of childhood cancer. CAC2 celebrates each and every member’s efforts to help close the large and persistent gap between funding needs to achieve this goal and available resources.
CAC2 doesn’t just applaud our member’s individual efforts but strives to act as a catalyst for research members to work collaboratively to effect positive change in the childhood cancer research community.
The Research and Treatment Interest Group’s four-pronged strategy:
1
Hosting educational conferences and webinars across a multi-disciplinary childhood cancer research audience to encourage exchange of information and build relationships
2
Providing information to respective members regarding co-funding research projects opportunities typically sourced by a member organization in need of additional funding
3
Developing online repositories for childhood cancer research progress including:
Childhood Cancer Fact Library
Childhood Cancer Research Project Database
4
Establishing the Ethics Think Tank Working Group to help identify best practices and potential ethical issues associated with pediatric cancer charities that fund researchers and the relationships between those organizations and the research recipients.
“Talent wins games, but teamwork and intelligence win championships.” – Michael Jordan
The Research and Treatment Interest Group strives to establish CAC2 as a credible resource for moving the field of pediatric cancer forward through thoughtful, progressive studies and projects.
Assorted News from the Last Week: ARPA-H announced $50 million to expand pediatric care across the country for patients with complex medical diseases. The program–Pediatric
Assorted News from the Last Week: Two articles of interest about childhood and AYA cancer survivorship: Microvascular skeletal muscle oxygenation linked to exercise capacity in
By CAC2 Staffer Bethany Lieberman In the December 15th, 2025, edition of the CAC2 Community News Digest, two articles stood out. They shed light on the